Skip to Main Content

Paper Details

KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma.
Histopathology
29
2018
Author NameAffiliation
Somak RoyUniversity of Pittsburgh Medical Center
  • 1 - 1

Datasets

Release 1.2